Jennison Associates LLC Astrazeneca PLC Transaction History
Jennison Associates LLC
- $167 Billion
- Q2 2025
A detailed history of Jennison Associates LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jennison Associates LLC holds 12,167,365 shares of AZN stock, worth $945 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
12,167,365
Previous 10,562,232
15.2%
Holding current value
$945 Million
Previous $776 Million
9.52%
% of portfolio
0.51%
Previous 0.55%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.04 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.2 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.67 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.44 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.42 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $241B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...